Immune Checkpoint Inhibitors and Non-Small-Cell Lung Cancer Management: 2018 Update
2019; Future Medicine; Volume: 11; Issue: 3 Linguagem: Inglês
10.2217/imt-2018-0167
ISSN1750-7448
AutoresOmar Abdel‐Rahman, Don Morris,
Tópico(s)Pancreatic and Hepatic Oncology Research
ResumoRecently, immune response evaluation criteria in solid tumor was proposed and it advocates for a different approach for response evaluation that takes into consideration the well-recorded phenomenon of pseudoprogression among solid tumor patients treated with these agents "
Referência(s)